The Future of Molecular Testing Reimbursement: MolDx, Prior Auth, and Payer Reforms

Navigating reimbursement for molecular and genetic testing remains one of the most complex challenges clinical laboratories face today. From payer utilization guidelines to the intricacies of MolDx and prior authorization programs, ensuring compliant payment requires a proactive and well-informed strategy. With new reforms on the horizon, driven by both payers and congressional action, now is the time to ensure your reimbursement practices are compliant while preparing for the changes ahead.

Join Lighthouse Lab Services and Quadax for a timely discussion on best practices to maximize reimbursement while minimizing denials in this ever-evolving space. Our expert speakers will share insider insights on the current reimbursement landscape, appeals strategies, and payer reforms on the horizon.

Learn what’s next for MolDx, prior auth, and payer policies in molecular and genetic testing, plus how to protect your bottom line.

Learning objectives:

• Identify the latest payer and MolDx requirements impacting molecular and genetic testing reimbursement.

• Apply best practices to improve compliance and reduce claim denials when billing for these services.

• Understand current legislative and payer initiatives aimed at reforming prior authorization practices.

• Anticipate what’s on the horizon for reimbursement and how labs can prepare for upcoming payer reforms.